AstraZeneca (AZNL)

10,190.00p
   
  • Change Today:
    -52.00p
  • 52 Week High: 13,250.00
  • 52 Week Low: 9,642.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 256,778
  • Market Cap: £128,818m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
31-Mar-25 Q1 13,588.00 3,402.00 188.00¢ n/a

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 41.3 0.3 +137% 280.00¢ 2.8%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,485.7 n/a -97% 287.00¢ 2.4%
31-Dec-22 44,351.00 2,501.00 212.00¢ 72.8 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 20.0 0.1 +242% 290.00¢ 2.0%
31-Dec-24 54,073.00 8,691.00 821.00¢ 17.5 1.3 +13% 310.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 57,559.42 17,969.28 669.78p 15.3 1.6 +10% 240.36p 0.0%
31-Dec-26 61,106.20 20,246.32 758.03p 13.5 1.0 +13% 252.79p 0.0%
31-Dec-27 64,584.86 22,217.43 837.06p 12.2 1.2 +10% 263.81p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.05

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,190.00p
Change Today -52.00p
% Change -0.51 %
52 Week High 13,250.00
52 Week Low 9,642.00
Volume 256,778
Shares Issued 1,264.16m
Market Cap £128,818m

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 26-Jun-2025

Time Volume / Share Price
16:04 291 @ 10,190.00p
16:04 50 @ 10,190.00p
16:04 50 @ 10,190.00p
16:04 50 @ 10,190.00p
16:04 50 @ 10,190.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page